GlassScriptPhysician profile
Firas Hamdan
NPI 1780623645
$12,108.16
in general payments reported to CMS, 2019-2025
13 companies · $3,321 in 2025
The $3,321 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,254 · 2020: $62.94 · 2021: $259 · 2022: $3,123 · 2023: $1,893 · 2024: $2,196 · 2025: $3,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,382 · Food and Beverage: $3,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,382.28 |
| Food and Beverage | $3,027.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $9,267.70 | 2019-2025 | Farapulse, Watchman Flx |
| Medtronic, INC. | $1,967.95 | 2022-2025 | Pulseselect, Arctic Front Advance, Affera Mapping System |
| Abbott Laboratories | $335.81 | 2021-2024 | Ensite Precision, Ensite, Merlin@Home |
| Atricure, INC. | $154.75 | 2021-2023 | |
| Biosense Webster, INC. | $110.42 | 2020-2024 | Carto 3 |
| Medtronic Vascular, INC. | $96.09 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.70 | 2021 | |
| Abiomed | $34.34 | 2023 | Impella |
| Novartis Pharmaceuticals Corporation | $19.96 | 2020 | |
| Braemar Manufacturing, LLC | $17.51 | 2019 | |
| Philips North America LLC | $13.63 | 2020 | |
| Amarin Pharma, INC. | $12.12 | 2019 | |
| Z-Medica, LLC | $8.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Firas Hamdan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.